The survival benefit of adjuvant radiotherapy for pathological T4N2M0 colon cancer in the Modern Chemotherapy Era: evidence from the SEER database 2004–2015
Source abstract
Abstract
Neoadjuvant chemoradiotherapy has been established as the standard treatment for patients with locally advanced rectal cancer. However, the role of radiotherapy (RT) has not been fully confirmed in advanced colon cancer (LACC). We postulated that patients with pathological T4N2 locally advanced colon cancer would benefit more from RT. 6715 pT4N2M0 colon cancer patients were included in the Surveillance, Epidemiology, and End Results (SEER) database. The primary endpoints were 5-year overall survival (OS) and cancer-specific survival (CSS). Propensity score matching (PSM) with Kaplan–Meier and Cox proportional hazards’ models was performed to estimate prognosis. Before PSM, patients underwent RT had better OS and CSS as compared to patients did not receive RT (OS: 40.1% vs 27.6%, p < .001; CSS: 49.6% vs 41.1%, p = .002). After PSM, 239 matched pairs were formed for further analysis. RT group also presented significantly improved prognosis (OS: 40.1% vs 25.7%, p = .008; CSS: 49.6% vs 38.2%, p = .042). Multivariable Cox regression analysis showed that RT was a protective factor [OS:Hazard ratio (HR) =0.677, 95% Confidence interval (CI): 0.532–0.862, p = .002; CSS: HR = 0.708, 95% CI: 0.533–0.941, p = .018]. For pT4N2M0 colon cancer patients, the addition of RT seems to confer survival benefit as compared to patients who did not receive RT.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Colorectal Cancer Surgical Treatments · Colorectal Cancer Screening and Detection · Colorectal and Anal Carcinomas
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of General Surgery, Jiangdu People’s Hospital Affiliated to Yangzhou University
Department of General Surgery, Nanjing Jiangbei People’s Hospital
Department of Gastroenterology, Jiangdu People’s Hospital Affiliated to Yangzhou University
Department of Radiotherapy, Jiangdu People’s Hospital Affiliated to Yangzhou University
References (20)
Show source-provided references
1. 10.1002/ijc.3193710.1002/ijc.31937 ↗
2. 10.3322/caac.2155110.3322/caac.21551 ↗
3. 10.1097/DCR.000000000000104610.1097/DCR.0000000000001046 ↗
4. 10.1016/j.radonc.2018.11.02610.1016/j.radonc.2018.11.026 ↗
5. 10.6004/jnccn.2018.703210.6004/jnccn.2018.7032 ↗
6. 10.1097/01.sla.0000257358.56863.ce10.1097/01.sla.0000257358.56863.ce ↗
7. 10.1016/j.ejca.2012.03.01610.1016/j.ejca.2012.03.016 ↗
8. 10.1245/s10434-015-4907-310.1245/s10434-015-4907-3 ↗
9. 10.1200/JCO.1993.11.6.111210.1200/JCO.1993.11.6.1112 ↗
10. 10.1007/s11605-018-3676-210.1007/s11605-018-3676-2 ↗
11. 10.1200/JCO.2004.01.02910.1200/JCO.2004.01.029 ↗
12. 10.1016/j.ejso.2012.05.00110.1016/j.ejso.2012.05.001 ↗
13. 10.1186/s13014-017-0790-310.1186/s13014-017-0790-3 ↗
14. 10.1093/jnci/djj39610.1093/jnci/djj396 ↗
15. 10.1007/DCR.0b013e3181ab580b10.1007/DCR.0b013e3181ab580b ↗
16. 10.1016/j.surg.2018.06.01510.1016/j.surg.2018.06.015 ↗
17. 10.1002/cncr.2052610.1002/cncr.20526 ↗
18. 10.1093/jnci/djk09210.1093/jnci/djk092 ↗
19. 10.1245/s10434-010-1158-110.1245/s10434-010-1158-1 ↗
20. 10.1016/S1470-2045(14)70227-X10.1016/S1470-2045(14)70227-X ↗